Inventor · disambiguated record
Roger Adami
Also filed as: ADAMI ROGER · ADAMI ROGER C
24 granted patents·27 pending applications·182 citations·filing 2000–2025
95Inventor score
Top patents by PatentIndex Score
51 records- 0195US9771582B2RNA interference compositions and methods for malignant tumorsNITTO DENKO CORP·Filed 2015·Granted Sep 26, 2017·13 cites·35 claims
- 0295US8501824B2Amino acid lipids and uses thereofQUAY STEVEN C·Filed 2011·Granted Aug 6, 2013·48 cites·27 claims
- 0393US9821067B2Lipopeptides for delivery of nucleic acidsMARINA BIOTECH INC·Filed 2015·Granted Nov 21, 2017·7 cites·11 claims
- 0492USRE48887ERNA interference compositions and methods for malignant tumorsNITTO DENKO CORP·Filed 2019·Granted Jan 11, 2022·2 cites·35 claims
- 0592US9580710B2Methods and compositions for treating malignant tumors associated with KRAS mutationNITTO DENKO CORP·Filed 2015·Granted Feb 28, 2017·7 cites·27 claims
- 0691US7939505B2Amino acid lipids and uses thereofMARINA BIOTECH INC·Filed 2008·Granted May 10, 2011·17 cites·31 claims
- 0790US10300018B2Compositions and methods for nanoparticle lyophile formsNITTO DENKO CORP·Filed 2016·Granted May 28, 2019·4 cites·29 claims
- 0888US10167253B2Ionizable compounds and compositions and uses thereofNITTO DENKO CORP·Filed 2016·Granted Jan 1, 2019·6 cites·16 claims
- 0987US11737982B2Compositions and methods for nanoparticle lyophile formsNITTO DENKO CORP·Filed 2019·Granted Aug 29, 2023·2 cites·4 claims
- 1087US9220785B2Lipopeptides for delivery of nucleic acidsMARINA BIOTECH INC·Filed 2012·Granted Dec 29, 2015·9 cites·11 claims
- 1187US6770740B1Crosslinked DNA condensate compositions and gene delivery methodsUNIV MICHIGAN·Filed 2000·Granted Aug 3, 2004·52 cites·35 claims
- 1286US11384051B2Ionizable compounds and compositions and uses thereofNITTO DENKO CORP·Filed 2018·Granted Jul 12, 2022·2 cites·14 claims
- 1386US10792299B2Methods and compositions for treating malignant tumors associated with kras mutationNITTO DENKO CORP·Filed 2017·Granted Oct 6, 2020·3 cites·19 claims
- 1483US8877729B2Amino acid lipids and uses thereofMARINA BIOTECH INC·Filed 2013·Granted Nov 4, 2014·4 cites·20 claims
- 1582US12311055B2Compositions and methods for nanoparticle lyophile formsNITTO DENKO CORP·Filed 2023·Granted May 27, 2025·0 cites·19 claims
- 1682US11413243B2Fusogenic compounds for delivery of biologically active moleculesNITTO DENKO CORP·Filed 2018·Granted Aug 16, 2022·1 cites·23 claims
- 1780US2022087531A1Rna interference compositions and methods for malignant tumorsNITTO DENKO CORP·Filed 2021·Application pending·0 cites
- 1879US12319643B2Ionizable compounds and compositions and uses thereofNITTO DENKO CORP·Filed 2022·Granted Jun 3, 2025·0 cites·12 claims
- 1978US9339461B2Arginine-based lipids for delivery of therapeuticsMARINA BIOTECH INC·Filed 2014·Granted May 17, 2016·2 cites·20 claims
- 2077US2025250226A1Ionizable compounds and compositions and uses thereofNITTO DENKO CORP·Filed 2025·Application pending·0 cites
- 2176US12440445B2Fusogenic compounds for delivery of biologically active moleculesNITTO DENKO CORP·Filed 2022·Granted Oct 14, 2025·0 cites·11 claims
- 2274USRE49229EMethods and compositions for treating malignant tumors associated with KRAS mutationNITTO DENKO CORP·Filed 2020·Granted Oct 4, 2022·0 cites·27 claims
- 2371US2024141342A1Rna interference delivery formulation and methods for malignant tumorsNITTO DENKO CORP·Filed 2023·Application pending·0 cites
- 2466US11708575B2RNA interference delivery formulation and methods for malignant tumorsNITTO DENKO CORP·Filed 2019·Granted Jul 25, 2023·0 cites·17 claims
- 2566US11352628B2Methods and compositions for treating malignant tumors associated with KRAS mutationNITTO DENKO CORP·Filed 2019·Granted Jun 7, 2022·0 cites·20 claims
- 2665US8183230B2Antimicrobial preservatives to achieve multi-dose formulation using beta-cyclodextrins for liquid dosage formsADAMI ROGER C·Filed 2005·Granted May 22, 2012·3 cites·7 claims
- 2762US2010112042A1Processes and Compositions for Liposomal and Efficient Delivery of Gene Silencing TherapeuticsMDRNA INC·Filed 2009·Application pending·0 cites
- 2861US2018353607A1Lipids for delivery of therapeuticsMARINA BIOTECH INC·Filed 2017·Application pending·0 cites
- 2960US9731016B2Tyrosine-based lipids for delivery of therapeuticsMARINA BIOTECH INC·Filed 2016·Granted Aug 15, 2017·0 cites·17 claims
- 3060US2022275373A1Methods and compositions for treating malignant tumors associated with kras mutationNITTO DENKO CORP·Filed 2022·Application pending·0 cites
- 3157US2015073038A1Delivery molecules for therapeuticsMARINA BIOTECH INC·Filed 2014·Application pending·0 cites
- 3256US2018002702A1Methods and compositions for treating malignant tumors associated with kras mutationNITTO DENKO CORP·Filed 2017·Application pending·0 cites
- 3356US2007293449A1Compositions and methods for delivery of double-stranded rnaNASTECH PHARM CO·Filed 2007·Application pending·0 cites
- 3455US2022049251A1dsRNA Directed to Coronavirus ProteinsNITTO DENKO CORP·Filed 2021·Application pending·0 cites
- 3551US2013039970A1Processes and Compositions for Liposomal and Efficient Delivery of Gene Silencing TherapeuticsMARINA BIOTECH INC·Filed 2012·Application pending·0 cites
- 3651US2017216227A1Delivery molecules for therapeuticsMARINA BIOTECH INC·Filed 2017·Application pending·0 cites
- 3750US2010129460A1Compounds and methods for peptide ribonucleic acid condensate particles for rna therapeuticsNASTECH PHARM CO·Filed 2006·Application pending·0 cites
- 3849US2008076701A1Dicer substrate rna peptide conjugates and methods for rna therapeuticsNASTECH PHARM CO·Filed 2007·Application pending·0 cites
- 3949US2007276134A1Compositions and methods for complexes of nucleic acids and organic cationsNASTECH PHARM CO·Filed 2007·Application pending·0 cites
- 4048US2007293657A1Complexes and methods of forming complexes of ribonucleic acids and peptidesNASTECH PHARM CO·Filed 2007·Application pending·0 cites
- 4148US2004110714A1Stabilized naked DNA compositionsFiled 2003·Application pending·0 cites
- 4248US2010240731A1Lipopeptides for delivery of nucleic acidsMDRNA INC·Filed 2010·Application pending·0 cites
- 4347US2012277289A1Activity generating delivery moleculesFAM RENATA·Filed 2010·Application pending·0 cites
- 4447US2008029084A1Device for improved peptide deliveryNASTECH PHARM CO·Filed 2007·Application pending·0 cites
- 4547US2007269892A1FORMULATIONS FOR INTRACELLULAR DELIVERY dsRNANASTECH PHARM CO·Filed 2007·Application pending·0 cites
- 4647US2014019151A1Wellness healthcare and personalized medicine systemPERMESYS INC·Filed 2013·Application pending·0 cites
- 4745US2015209283A1Processes and compositions for liposomal and efficient delivery of gene silencing therapeuticsMARINA BIOTECH INC·Filed 2015·Application pending·0 cites
- 4844US2007275923A1CATIONIC PEPTIDES FOR siRNA INTRACELLULAR DELIVERYNASTECH PHARM CO·Filed 2007·Application pending·0 cites
- 4939US2013072424A1Compounds and methods for peptide ribonucleic acid condensate particles for rna therapeuticsADAMI ROGER C·Filed 2012·Application pending·0 cites
- 5037US2011130327A1Multi-Arm Amines and Uses ThereofMARINA BIOTECH INC·Filed 2010·Application pending·0 cites
Showing the top 50 of 51 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Roger Adami files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →